5-methoxyindole-2-carboxylic acid has been researched along with Cerebral Ischemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forster, MJ; Li, R; Li, W; Liu, R; Ren, M; Simpkins, JW; Sumien, N; Thangthaeng, N; Wu, J; Yan, LJ; Yang, S | 1 |
1 other study(ies) available for 5-methoxyindole-2-carboxylic acid and Cerebral Ischemia
| Article | Year |
|---|---|
Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury.
Topics: Adenosine Triphosphate; Administration, Oral; Animals; Brain; Brain Ischemia; Cell Death; Dihydrolipoamide Dehydrogenase; Disease Models, Animal; Gene Expression Regulation; Indoles; Ischemic Preconditioning; Male; Mitochondria; Mitochondrial Proteins; NAD(P)H Dehydrogenase (Quinone); Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Stroke | 2017 |